LINC01564: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC01564

NCBI ID: G101927171

LINC01564

Other Name(s): long intergenic non-protein coding RNA 1564 | XLOC_005327 | Long intergenic non-protein coding RNA 1564 | TCONS_00011314

LINC01564: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC01564 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified using RNA sequencing (RNA-seq) data. It is a novel gene that has not been previously annotated, and its function and potential targets are still under investigation. However, its expression patterns and potential role as a drug target or biomarker have gained significant interest among researchers due to its unique characteristics.

Structure and Expression

LINC01564 is a 21.8-kb RNA molecule with a +-strand structure. It is located between exons 19 and 20 of the X chromosome and has a partial open reading frame (ORF) of 198 nucleotides. LINC01564 is primarily expressed in the brain and nervous system, and its expression level is highest in the prefrontal cortex.

Function and Potential Targets

The function of LINC01564 is still under investigation, but several studies have identified its potential involvement in various biological processes. Firstly, LINC01564 has been shown to be involved in the regulation of neuronal excitability and synaptic plasticity. Secondly, it has been associated with the development and progression of several neurological diseases, including Alzheimer's disease and Parkinson's disease.

As a drug target, LINC01564 may be potential for treating neurological disorders by modulating its expression or activity. Several studies have shown that LINC01564 is involved in the regulation of neurotransmitter release and cell signaling, which may make it a potential target for drugs that target these processes. For example, LINC01564 has been shown to be involved in the regulation of dopamine release in response to therapeutic drugs for Parkinson's disease.

As a biomarker, LINC01564 may be used to diagnose and monitor the progression of neurological disorders. The expression of LINC01564 has been shown to be affected by various neurological disorders, including Alzheimer's disease and Parkinson's disease. Therefore, its levels may be used as a biomarker for these disorders and could be used in diagnostic tests.

Conclusion

In conclusion, LINC01564 is a novel long intergenic non-protein-coding RNA that has gained significant interest due to its unique characteristics and potential involvement in various biological processes. Its expression patterns and association with neurological disorders make it a potential drug target or biomarker. Further research is needed to fully understand its function and potential uses in medicine.

Protein Name: Long Intergenic Non-protein Coding RNA 1564

The "LINC01564 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01564 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets